Salmeterol/Fluticasone Propionate via Diskus™ Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids

被引:0
|
作者
Alexander Chuchalin
Loretta Jacques
Lucy Frith
机构
[1] Pulmonology Research Institute,
[2] GlaxoSmithKline Research and Development Limited,undefined
[3] Russian Research Institute of Pulmonology,undefined
来源
关键词
Asthma; Fluticasone Propionate; Salmeterol; Peak Expiratory Flow; Mometasone Furoate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:169 / 181
页数:12
相关论文
共 50 条
  • [31] Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma
    Catherine M Houghton
    Naomi Lawson
    Zoe L Borrill
    Claire L Wixon
    Sally Yoxall
    Stephen J Langley
    Ashley Woodcock
    Dave Singh
    Respiratory Research, 8
  • [32] Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma
    Houghton, Catherine M.
    Lawson, Naomi
    Borrill, Zoe L.
    Wixon, Claire L.
    Yoxall, Sally
    Langley, Stephen J.
    Woodcock, Ashley
    Singh, Dave
    RESPIRATORY RESEARCH, 2007, 8 (1)
  • [33] Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: A comparison with fluticasone propionate
    Rojas, Ramon A.
    Paluga, Igor
    Goldfrad, Caroline H.
    Duggan, Marie T.
    Barnes, Neil
    JOURNAL OF ASTHMA, 2007, 44 (06) : 437 - 441
  • [34] Efficacy of Advair Diskus 250/50 (fluticasone propionate/salmeterol) in patients previously naive to COPD maintenance therapy
    Anzueto, AR
    Sense, W
    Yates, J
    Brown, C
    Knobil, K
    CHEST, 2004, 126 (04) : 808S - 808S
  • [35] Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
    van Noord, JA
    Schreurs, AJM
    Mol, SJM
    Mulder, PGH
    THORAX, 1999, 54 (03) : 207 - 212
  • [36] Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by Diskus device in patients with asthma treated with or without inhaled corticosteroids
    Wolfe, J
    Rooklin, A
    Grady, J
    Munk, ZM
    Stevens, A
    Prillaman, B
    Duke, S
    Harding, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (06) : 1153 - 1161
  • [37] Comparison between compliance of fluticasone propionate Diskhaler and of fluticasone propionate Diskus in adult bronchial asthma patients
    Hasegawa, Takashi
    Suzuki, Eiichi
    Fujimori, Katsuya
    Sakagami, Takuro
    Toyabe, Shinichi
    Akazawa, Kouhei
    Kawano, Kenji
    Haraguchi, Michihiko
    Toyama, Joji
    Arakawa, Masaaki
    Satoh, Hiroshi
    Gejyo, Fumitake
    RESPIRATION, 2006, 73 (05) : 680 - 684
  • [38] Fluticasone propionate/salmeterol Diskus® combination product provides superior asthma control compared with fluticasone propionate and salmeterol alone in patients previously receiving PRN short-acting beta2-agonists alone
    Rosenthal, RR
    Blake, K
    Strek, M
    Lange, M
    House, KW
    Vandermeer, AK
    Shah, TP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S245 - S245
  • [39] Comparative safety and efficacy of fluticasone propionate plus salmeterol via Diskus® versus fluticasone propionate in subjects with asthma greater than or equal to 55 and 65 years of age
    Ortega, H.
    Stempel, D.
    Sutton, L.
    Lincourt, W.
    Frith, L.
    Forth, R.
    Busse, W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S7 - S7
  • [40] The comparative study of the efficacy of fluticasone propionate/salmeterol combination versus fluticasone propionate alone in moderate asthma
    Breskovska, G.
    Kaeva, B.
    Stojkovoc, J.
    Stevcevska, G.
    Gligorovski, L.
    Gerovski, B.
    ALLERGY, 2008, 63 : 606 - 607